Management of newly diagnosed diabetes: home or hospital?

L Lowes1, J W Gregory

  • 1Nursing, Health and Social Care Research Centre, Wales, College of Medicine, Cardiff University, Cardiff, Wales, UK. Lowes@cardiff.ac.uk

Insights

Type 1 diabetes management for children can occur at home or in the hospital. Early stabilization for pediatric diabetes may not always require hospital admission, depending on the child

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Childhood Chronic Illnesses

Background:

  • Type 1 diabetes is a growing concern in childhood.
  • Effective diabetes management requires insulin, blood glucose monitoring, and dietary adherence.
  • Initial medical interventions for newly diagnosed diabetes are tailored to the child's presentation.

Purpose of the Study:

  • To review evidence on hospital versus home-based treatment for newly diagnosed type 1 diabetes in children.
  • To discuss the benefits and drawbacks of various initial management strategies.
  • To describe the Cardiff approach to home management.

Main Methods:

  • Literature review of existing evidence.
  • Comparative analysis of hospital-based vs. home-based initial management.
  • Description of a specific home management protocol (Cardiff approach).

Main Results:

  • Hospital admission is reserved for severe cases requiring intravenous therapy for dehydration, electrolyte imbalance, or ketoacidosis.
  • Mild to moderately symptomatic children can often be managed with subcutaneous insulin, diet, and fluids at home.
  • Home-based management may be a viable option for stabilizing children at diagnosis.

Conclusions:

  • Initial management of type 1 diabetes in children can be individualized based on clinical condition.
  • Home-based care is a potential alternative to hospitalization for stable pediatric patients.
  • Evidence supports exploring different approaches to optimize initial type 1 diabetes management in children.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...